Decreased serum Annexin A1 levels in Kawasaki disease with coronary artery aneurysm
- PMID: 32316027
- DOI: 10.1038/s41390-020-0898-2
Decreased serum Annexin A1 levels in Kawasaki disease with coronary artery aneurysm
Abstract
Background: Kawasaki disease (KD) is an acute and systemic vasculitis whose etiology remains unclear. The most crucial complication is the formation of coronary artery aneurysm (CAA). Annexin A1 (ANXA1) is an endogenous anti-inflammatory agent and pro-resolving mediator involved in inflammation-related diseases. This study sought to investigate the serum ANXA1 levels in KD patients and further explore the relationship between ANXA1 and CAA, as well as additional clinical parameters.
Methods: Serum samples were collected from 95 KD patients and 39 healthy controls (HCs). KD patients were further divided into two groups: KD with CAAs (KD-CAAs) and KD non-CAAs (KD-NCAAs). Serum levels of ANXA1 and interleukin-6 (IL-6) were determined using enzyme-linked immunosorbent assays.
Results: Serum ANXA1 levels in the KD group were significantly lower than in the HC group. In particular, serum ANXA1 levels were substantially lower in the KD-CAA groups. Moreover, serum ANXA1 levels were positively correlated with N%, C-reactive protein (CRP), and IL-6 but negatively correlated with L% in the KD group. Positive correlations between serum ANXA1 levels and erythrocyte sedimentation rate (ESR), IL-6, and D-dimer (DD) were observed in the KD-CAA group.
Conclusions: ANXA1 may be involved in the development of KD, and downregulation of ANXA1 may lead to the hypercoagulability seen in KD.
Impact: For the first time, it was demonstrated that serum ANXA1 levels were significantly decreased in Kawasaki disease with coronary artery aneurysms. ANXA1 might be involved in the acute phase of Kawasaki disease. Low serum concentrations of ANXA1 might lead to the hypercoagulability stage in Kawasaki disease. ANXA1 might be a potential therapeutic target for patients with Kawasaki disease.
Similar articles
-
The relationship between TNF-like protein 1A and coronary artery aneurysms in children with Kawasaki disease.Clin Exp Med. 2022 Feb;22(1):57-63. doi: 10.1007/s10238-021-00729-5. Epub 2021 Jul 7. Clin Exp Med. 2022. PMID: 34232416
-
Serum NLRP3: A potential marker for identifying high-risk coronary arterial aneurysm in children with Kawasaki disease.Cytokine. 2024 Aug;180:156667. doi: 10.1016/j.cyto.2024.156667. Epub 2024 Jun 9. Cytokine. 2024. PMID: 38857561
-
Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease.Heart Surg Forum. 2021 Jul 26;24(4):E611-E618. doi: 10.1532/hsf.3833. Heart Surg Forum. 2021. PMID: 34473042
-
The serum concentration of soluble interleukin-2 receptor in patients with Kawasaki disease.Ann Clin Biochem. 2017 Mar;54(2):209-213. doi: 10.1177/0004563216677583. Epub 2017 Jan 12. Ann Clin Biochem. 2017. PMID: 28081636 Review.
-
Immune and non-immune mechanisms that determine vasculitis and coronary artery aneurysm topography in Kawasaki disease and MIS-C.Autoimmun Rev. 2023 Feb;22(2):103240. doi: 10.1016/j.autrev.2022.103240. Epub 2022 Dec 7. Autoimmun Rev. 2023. PMID: 36496111 Review.
Cited by
-
Retrospective analysis of children diagnosed with Kawasaki disease.Turk J Med Sci. 2023 Aug;53(4):979-989. doi: 10.55730/1300-0144.5662. Epub 2023 Aug 18. Turk J Med Sci. 2023. PMID: 38031949 Free PMC article.
-
Anti-inflammatory Treatment of Kawasaki Disease: Comparison of Current Guidelines and Perspectives.Front Med (Lausanne). 2021 Nov 30;8:738850. doi: 10.3389/fmed.2021.738850. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34917629 Free PMC article. Review.
References
-
- Burns, J. C. History of the worldwide emergence of Kawasaki disease. Int. J. Rheum. Dis. 21, 13–15 (2018). - DOI
-
- Newburger, J. W., Takahashi, M. & Burns, J. C. Kawasaki Disease. J. Am. Coll. Cardiol. 67, 1738–1749 (2016). - DOI
-
- Nakamura, Y. Kawasaki disease: epidemiology and the lessons from it. Int. J. Rheum. Dis. 21, 16–19 (2018). - DOI
-
- Kato, H. et al. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am. J. Cardiol. 49, 1758–1766 (1982). - DOI
-
- Shulman, S. T. & Rowley, A. H. Kawasaki disease: insights into pathogenesis and approaches to treatment. Nat. Rev. Rheumatol. 11, 475–482 (2015). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous